We are live on
!
Find out more
MJP
Michael J. Puzo Portfolio holdings
AUM
$343M
1-Year Est. Return
18.42%
This Fund
S&P 500
This Quarter
Est. Return
+11.48%
1 Year Est. Return
+18.42%
3 Year Est. Return
+60.27%
5 Year Est. Return
+82.68%
10 Year Est. Return
+283.93%
AUM
$277M
AUM Growth
+$13.8M
(+5.3%)
Cap. Flow
-$13M
Cap. Flow
% of AUM
-4.68%
Top 10 Holdings %
Top 10 Hldgs %
39.44%
Holding
77
New
3
Increased
13
Reduced
38
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$414K |
| 2 |
Nucor
NUE
|
+$245K |
| 3 |
Gilead Sciences
GILD
|
+$214K |
| 4 |
Cisco
CSCO
|
+$205K |
| 5 |
Xylem
XYL
|
+$175K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$3.22M |
| 2 |
Medtronic
MDT
|
+$1.58M |
| 3 |
Nike
NKE
|
+$1.46M |
| 4 |
PayPal
PYPL
|
+$918K |
| 5 |
Edwards Lifesciences
EW
|
+$899K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.02% |
| 2 | Technology | 22.12% |
| 3 | Industrials | 14.87% |
| 4 | Financials | 8.2% |
| 5 | Consumer Discretionary | 6.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Bristol-Myers Squibb
BMY
$130B
| $652K | 0.24% |
9,060
| – | – |
|
52
Bank OZK
OZK
$5.62B
| $646K | 0.23% |
16,135
-3,040
| -16% | -$131K |
|
|
53
Edwards Lifesciences
EW
$48.2B
| $619K | 0.22% |
8,300
-11,660
| -58% | -$899K |
|
54
Colgate-Palmolive
CL
$74.2B
| $561K | 0.2% |
7,125
-15
| -0.2% | -$1.13K |
|
55
Unilever
UL
$144B
| $550K | 0.2% |
9,710
-4,814
| -33% | -$258K |
|
56
Sysco
SYY
$40.7B
| $413K | 0.15% |
5,400
-500
| -8% | -$40.4K |
|
57
Dover
DOV
$27.4B
| $403K | 0.15% |
2,975
| – | – |
|
58
Texas Instruments
TXN
$253B
| $363K | 0.13% |
2,200
-200
| -8% | -$33.4K |
|
59
Paychex
PAYX
$42.3B
| $347K | 0.13% |
3,000
| – | – |
|
60
Ecolab
ECL
$79.6B
| $324K | 0.12% |
2,225
| – | – |
|
61
Bank of Montreal
BMO
$127B
| $317K | 0.11% |
3,500
| – | – |
|
62
Idexx Laboratories
IDXX
$44.9B
| $265K | 0.1% |
650
| – | – |
|
63
Coca-Cola
KO
$380B
| $262K | 0.09% |
4,125
| – | – |
|
64
EOG Resources
EOG
$74.4B
| $242K | 0.09% |
1,865
-200
| -10% | -$26.6K |
|
|
65
Nucor
NUE
$60.5B
| $237K | 0.09% |
+1,800
| New | +$245K |
|
66
American Express
AXP
$227B
| $236K | 0.09% |
1,600
| – | – |
|
|
67
Gilead Sciences
GILD
$167B
| $232K | 0.08% |
+2,700
| New | +$214K |
|
|
68
Cisco
CSCO
$456B
| $214K | 0.08% |
+4,500
| New | +$205K |
|
69
Wells Fargo
WFC
$263B
| $206K | 0.07% |
5,000
| – | – |
|
70
Empire State Realty Series ES
ESBA
$1.57B
| $106K | 0.04% |
16,200
-7,600
| -32% | -$52.7K |
|
Similar funds
WP
LWM
CWM
BA
TCMNY
SMG
FMB
AWA
Michael J. Puzo's Q4 2022 Portfolio in Review
As of Q4 2022, Michael J. Puzo held 77 positions worth $277M, up 5.3% from $263M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Michael J. Puzo withdrew a net $13M in Q4 2022, closing 1 position and reducing 38 holdings. Its largest reduction was Walt Disney, cutting an estimated $3.22M.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 27% a quarter earlier, followed by Technology and Industrials.
Against the trend, Michael J. Puzo opened a new position in Nucor worth $237K.
- Michael J. Puzo's largest Q4 2022 buy was Nucor: 1,800 shares worth $237K.
- Michael J. Puzo added most to Becton Dickinson in Q4 2022, an estimated $414K increase.
- Michael J. Puzo's biggest Q4 2022 reduction was Walt Disney, cutting an estimated $3.22M.
- Michael J. Puzo's ten largest holdings make up 39% of its $277M portfolio in Q4 2022.
- Michael J. Puzo opened 3 new positions and closed 1 in Q4 2022.
- Michael J. Puzo's portfolio value rose 5.3% quarter-over-quarter to $277M.
Based on Michael J. Puzo's 13F filing for Q4 2022, filed 9 Feb 2023.